about
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the fiel...
Read More
41.44
-2.07
(-4.76%)
571.0K
XNAS Volume
XNAS 08 Jan, 2026 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Nektar Therapeutics Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..